IVERIC bio, Inc. (OPHT) [Rocket]

In millions, except per share items	Dec-31-22	Dec-31-21	Dec-31-20	Dec-31-19	Dec-31-18	Dec-31-17	Dec-31-16	Dec-31-15
	10-K	10-K	10-K	10-K	10-K	10-K	10-K	10-K
Operating expenses:
Research and development	117.0	85.1	62.8	39.6	41.7	66.3	196.3	131.0
General and administrative	72.9	29.7	26.0	21.6	23.6	35.7	50.2	44.0
Total operating expenses	382.2	114.8	88.7	61.3	65.3	102.0	246.5	175.0
Loss from operations	-189.9	-114.8	-88.7	-61.3	-65.3	108.0	-195.6	-123.5
Interest income, net	2.3	0.2	0.5	2.2	2.4	1.5	1.7	1.0
Other (expense) income, net	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.1
Loss before income tax benefit	-185.2	-114.5	-88.2	-59.0	62.0	109.5	-193.8	-122.5
Income tax benefit			3.7	0.1	1.1	4.7	0.4	16.8
Net loss	-185.2	-114.5	-84.5	-58.9	63.1	114.2	-193.4	-105.7

Net loss per common share:
Basic (in usd per share)	($1.53)	($1.12)	($1.14)	($1.39)	$1.70	$3.18	($5.45)	($3.06)
Diluted (in usd per share)	($1.53)	($1.12)	($1.14)	($1.39)	$1.70	$3.17	($5.45)	($3.06)

Weighted average common shares outstanding:
Basic (in shares)	121.0	101.9	74.2	42.2	37.1	35.9	35.5	34.6
Diluted (in shares)	121.0	101.9	74.2	42.2	37.1	36.0	35.5	34.6